ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : University of Wisconsin Comprehensive Cancer Center

Include trials that are no longer recruiting patients.

7 studies were found.
1.Recruiting3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
2.RecruitingBortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
Conditions: adult non-Hodgkin's lymphoma; adult solid tumor; Multiple Myeloma; refractory plasma cell neoplasm
3.RecruitingCombination Chemotherapy in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific
4.RecruitingCombination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
5.RecruitingDoxercalciferol Before Surgery in Treating Localized Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
6.RecruitingDoxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; de novo myelodysplastic syndromes; ...
7.RecruitingIrinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: unspecified adult solid tumor, protocol specific

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act